C-glucopyranosyl-1,2,4-triazoles as new potent inhibitors of glycogen phosphorylase

Research output: Contribution to journalArticle

32 Citations (Scopus)


Glycogen phosphorylase inhibitors are considered as potential antidiabetic agents. 3-(β-d-Glucopyranosyl)-5-substituted-1,2,4-triazoles were prepared by acylation of O-perbenzoylated N1-tosyl-C-β-d-glucopyranosyl formamidrazone and subsequent removal of the protecting groups. The best inhibitor was 3-(β-d-glucopyranosyl)-5-(2-naphthyl)-1,2,4-triazole (K i = 0.41 μM against rabbit muscle glycogen phosphorylase b).

Original languageEnglish
Pages (from-to)612-615
Number of pages4
JournalACS Medicinal Chemistry Letters
Issue number7
Publication statusPublished - Jul 11 2013


  • 1,2,4-Triazole
  • C-glucopyranosyl derivative
  • bioisoster
  • glycogen phosphorylase
  • inhibitor

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint Dive into the research topics of 'C-glucopyranosyl-1,2,4-triazoles as new potent inhibitors of glycogen phosphorylase'. Together they form a unique fingerprint.

  • Cite this